GDRX — Goodrx Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $767.37m
- $993.81m
- $796.85m
Annual cashflow statement for Goodrx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.3 | -32.8 | -8.87 | 16.4 | 30.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 168 | 146 | 127 | 108 | 88.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.8 | -20.3 | -21.9 | 2.09 | -56.4 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 179 | 147 | 138 | 184 | 168 |
| Capital Expenditures | -34.5 | -55.2 | -55.8 | -70.3 | -74 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -144 | -155 | 0 | 0 | -45.9 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -179 | -210 | -55.8 | -70.3 | -120 |
| Financing Cash Flow Items | -58.5 | -20.6 | -64.1 | -30.7 | -13.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -30.5 | -120 | -167 | -337 | -234 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -30.5 | -184 | -84.9 | -224 | -187 |